Announcements Trials
Browse Landscape

Phase

Phase 2 166Phase 3 56Phase 1 22Phase 1/2 20Phase 2/3 11Phase NA 10Phase 4 4Phase EARLY_PHASE1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 4Colonic Neoplasms 2Stomach Neoplasms 1Neuritis 1Mucositis 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1Borderline Resectable Pancreatic Adenocarcinoma 1

Interventions

Fluorodeoxyglucose F18 3Oncolytic Virotherapy 2Magnetic Resonance Spectroscopy 2Cisplatin 2weifuchun 1sodium thiosulfate 1s-formylglutathione hydrolase 1lenvatinib 1gallium 68 PSMA-11 1X-Rays 1Vitamins 1Trastuzumab 1Specimen Handling 1Radiation 1Platinum 1Oxaliplatin 1Nelfinavir 1Hyperthermic Intraperitoneal Chemotherapy 1Fluorouracil 1FAPI-46 1Esomeprazole 1Epirubicin 1Drug Therapy, Combination 1Doxorubicin 1Cytoreduction Surgical Procedures 1Carbohydrates 1Amoxicillin 168Ga-DKFZ-PSMA-11 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Stomach Neoplasms × Oxaliplatin × Clear all
NCT07356466 2026-01-21

FUGES032

Fujian Medical University

Phase EARLY_PHASE1 Enrolling by invitation
100 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡